Ensysce Biosciences, Inc. Reports annual revenue of $0.0
Company Records $10.6 million loss
By USInMinutes
Published - Mar 18, 2024, 12:33 AM ET
Last Updated - Mar 18, 2024, 12:33 AM EDT
Ensysce Biosciences, Inc. [LACQU] has reported $0.0 in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $10.6 million.